期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

FKS与光滑念珠菌棘白菌素耐药 被引量：1

Advances in research on FKS mutation and echinocandin resistance of Candida glabrata
下载PDF
导出
摘要 近年来,光滑念珠菌侵入性感染及其耐棘白菌素治疗失败的病例不断增多,深入研究其耐药机制十分有必要。Fks突变在光滑念珠菌棘白菌素耐药发生的过程中有着极其重要的地位,其与棘白菌素的MIC值及体内治疗结果密切相关,且有很多因素可以对Fks突变的发生及其作用产生影响。 The proportion of systemic fungal infections in humans caused by C. glabrata has increased significantly in recent years,and in the same time,cases about echinocandins therapeutic failure to this pathogen has been reported more and more. FKS mutation has a significant role in the growth of MIC values and echinocandin resistance,and a lot of elements can effect it.
作者 高盈 佘晓东 刘维达
机构地区 北京协和医学院中国医学科学院皮肤病研究所真菌科
出处 《中国真菌学杂志》 CSCD 2014年第6期364-367,363,共5页 Chinese Journal of Mycology
基金 国家973项目(2013CB531605) 江苏省自然基金青年基金(BK20130063)
关键词 光滑念珠菌 Fks突变 MIC 棘白菌素耐药 Candida glabrata Fks mutation MIC echinocandins resistance
分类号 R379.4 [医药卫生—病原生物学]
  • 相关文献

参考文献21

  • 1Arendrup MC. Epidemiology of invasive candidiasis[J]. Curr Opin Crit Care, 2010,16 (5) : 445-452.
  • 2Katiyar SK, Alastruey-Izquierdo A, Healey KR, et al. Fksl and Fks2 are functionally redundant but differentially regula- ted in Candida glabrata : implications for echinocandin re- sistance[J]. Antimicrobial and chemotherapy, 2012,12 ( 56 ) : 6304-6309.
  • 3Alexander BD, Johnson MD, Pfeiffer CD, et al. Increasing eehinocandin resistance in Oandida glabrata : clinical failure correlates with presence of FKS mutations and elevated mini- mum inhibitory concentrations [J]. Clinical Infectious Dis- ease,2013,56(12) :1724 -1732.
  • 4Castanheira M, Woosley LN,Pfaller MA,et al. Low preva- lence of fksl hotspot 1 mutations in a worldwide collection of Candida spp[J]. Antimicrobial and chemotherapy, 2010, 54 (6) ,2655-2659.
  • 5Walker LA, Gow NA, Munro CA. Fungal echinocandin re- sistance[J]. Fungal Genet Biol,2010,47(2) :117-126.
  • 6Cowen LE. The evolution of fungal drug resistance: modula ring the trajectory from genotype to phenotype[J]. Nat Rev Microbiol,2008,6(3) : 187- 198.
  • 7Park, S, R. Kelly, N. Kahn, et al. Specific substitutions in the echinocandin target Fkslp account for reduced susceptibility of rare laboratory and clinical Candida sp Isolates[J]. Anti microb Agents Chemother,2005,49(8) :3264-3273.
  • 8Garcia-Effron,G,S. Lee,S. Park,et al. Effect of Candida gla- brata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3- -D-glucan synthase: implication for the existing susceptibility breakpoint[J]. Antimierob Agents Chemother,2009,53(9) :3690-3699.
  • 9Nicholas D. Beyda,Julie John,Ahdullah Kilic,et al. FKS mu- tant Candida glabrata ;risk factors and outcomes in patients with candidemia[J]. Clinical Infectious Diseases, 2014, 59 (6) :819-825.
  • 10Mariana Castanheira, Leah N. Woosley, et al. Frequency of fks Mutations among Candida glabrata Isolates from a 10- Year Global Collection of Bloodstream Infection Isolates [J]. Antimicrob Agents Chemother, 2014,58 (1) : 577.

同被引文献24

引证文献1

二级引证文献3

中国真菌学杂志
2014年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部